Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2012 May;47(5):421-8.
doi: 10.1002/ppul.21567. Epub 2011 Oct 17.

Bronchodilator responsiveness in wheezy infants and toddlers is not associated with asthma risk factors

Jason Debley  1 , Sanja Stanojevic, Amy G Filbrun, Padmaja Subbarao
Affiliations
Clinical Trial

Bronchodilator responsiveness in wheezy infants and toddlers is not associated with asthma risk factors

Jason Debley et al. Pediatr Pulmonol. 2012 May.

Abstract

Background: There are limited data assessing bronchodilator responsiveness (BDR) in infants and toddlers with recurrent wheezing, and factors associated with a positive response.

Objectives: In a multicenter study of children ≤ 36 months old, we assessed the prevalence of and factors associated with BDR among infants/toddlers with recurrent episodes of wheezing.

Methods: Forced expiratory flows and volumes using the raised-volume rapid thoracic compression method were measured in 76 infants/toddlers [mean (SD) age 16.8 (7.6) months] with recurrent wheezing before and after administration of albuterol. Prior history of hospitalization or emergency department treatment for wheezing, use of inhaled or systemic corticosteroids, physician treatment of eczema, environmental tobacco smoke exposure, and family history of asthma or allergic rhinitis were ascertained.

Results: Using the published upper limit of normal for post bronchodilator change (FEV(0.5) ≥ 13% and/or FEF(25-75) ≥ 24%) in healthy infants, 24% (n = 18) of children in our study exhibited BDR. The BDR response was not associated with any clinical factor other than body size. Dichotomizing subjects into responders (defined by published limits of normal) or by quartile to identify children with the greatest change from baseline (4th quartile vs. other) did not identify any other factor associated with BDR.

Conclusions: Approximately one quarter of infants/toddlers with recurrent wheezing exhibited BDR at their clinical baseline. However, BDR in wheezy infants/toddlers was not associated with established clinical asthma risk factors.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Figure 2
Figure 2
See this image and copyright information in PMC

Comment in

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Martinez FD. Development of wheezing disorders and asthma in preschool children. Pediatrics. 2002;109(2 Suppl):362–367. - PubMed
    1. Morton RL, Sheikh S, Corbett ML, Eid NS. Evaluation of the wheezy infant. Ann Allergy Asthma Immunol. 2001;86(3):251–256. - PubMed
    1. Guerra S, Lohman IC, Halonen M, Martinez FD, Wright AL. Reduced interferon gamma production and soluble CD14 levels in early life predict recurrent wheezing by 1 year of age. Am J Respir Crit Care Med. 2004;169(1):70–76. - PubMed
    1. NIH/NHLBI. National Asthma Education and Prevention Program Expert Panel Report 2: Guidelines for the Diagnosis and Management of Asthma. - PubMed
    1. Global Strategy for Asthma Management and Prevention, Global Initiative for Asthma (GINA) 2010 Available from: http://www.ginasthma.org/Guidelines/guidelines-resources.html.

Publication types